Oxcarbazepine Tablet, Film Coated
Product Images NDC 71335-0090
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 71335-0090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Oxcarbazepine 01)
Figure 1 (Oxcarbazepine 02)
Figure 2 (Oxcarbazepine 03)
The text is a plot showing the seizure rate over time for two treatment groups (Oxcarbazepine and Placebo) using a log-rank test with a p-value of 0.046. The x-axis represents days from the first dose to the first seizure, while the y-axis represents the percentage of participants remaining seizure-free.*
Figure 3 (Oxcarbazepine 04)
Figure 4 (Oxcarbazepine 05)
This appears to be output data from a statistical analysis of a treatment intervention. The treatment groups are labelled as "HIGH" and "LOW". The "log-rank test" was applied and yielded a P-value of "0.0001". The data also represents the "Time to exit" in days, with measurements taken at various intervals (10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, and 130 days). However, without additional information, it is unclear what the "Exitrate" refers to.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.